GlassScriptPhysician profile
Thomas Walter Brown
NPI 1932164209
$7,370.56
in general payments reported to CMS, 2019-2025
18 companies · $52.58 in 2025
The $52.58 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $2,257 · 2021: $111 · 2022: $1,337 · 2023: $307 · 2024: $3,053 · 2025: $52.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,162 · Food and Beverage: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,161.74 |
| Food and Beverage | $1,251.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $2,403.04 | 2019-2022 | |
| Arthrex, INC. | $1,864.57 | 2020-2024 | |
| Smoky Mountain Surgical LLC | $1,229.04 | 2023-2025 | |
| Medacta USA, INC. | $1,150.96 | 2024 | |
| Smith+Nephew, INC. | $273.03 | 2020-2025 | Real Intelligence, Healicoil, Spatial Frame |
| Stryker Corporation | $148.15 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $71.81 | 2024 | Iovera, Zilretta, Exparel |
| Medtronic, INC. | $45.55 | 2022-2024 | Intellis Adaptivestim |
| Pfizer INC. | $27.16 | 2019-2020 | |
| Djo, LLC | $24.18 | 2024 | Cmf |
| Eisai INC. | $21.51 | 2022 | |
| Linvatec Corporation | $18.55 | 2022 | |
| Pacira Therapeutics, INC. | $18.51 | 2020 | |
| Medtronic Vascular, INC. | $17.91 | 2020 | |
| Sanara Medtech INC. | $16.06 | 2023 | Celleraterx |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.95 | 2021 | |
| Anika Therapeutics, INC. | $13.46 | 2024 | Integrity |
| Dompe US, INC. | $13.12 | 2024 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.